Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies - A randomized, controlled study

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue 9, 2006, Pages 1053-1059

  Ruud, Ellen ^a   Holmstrøm, Henrik ^a   De Lange, Charlotte ^a   Hogstad, Ellen M ^b   Wesenberg, Finn ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cancer children; Central venous line; Venous thrombosis

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BRAIN TUMOR; CANCER DIAGNOSIS; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; JUGULAR VEIN; LOW DRUG DOSE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; VENOUS THROMBOEMBOLISM;

EID: 33748636265     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1080/08035250600729092     Document Type: Article

References (28)

1. Fratino G, Molinari AC, Parodi S, Long S, Saracco P, Castagnola E, et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol 2005;16: 648-54.
2. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of venous thromboembolic complications. J Pediatr 1998;133:770-6.
3. van Rooden CJ, Schippers EF, Barge RMY, Rosendaal FR, Guiot HFL, van der Meer FJM, et al. Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: A prospective study. J Clin Oncol 2005;23:2655-60.
4. Raad II, Luna M, Khalil SAM, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994;271: 1014-6.
5. Journeycake JM, Buchanan GR. Thrombotic complications of central venous catheters in children. Curr Opin Hematol 2003;10:369-74.
6. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003;21:3665-75.
7. Bern MM, Lokich JJ, Wallach SR, Bothe A, Benotti PN, Arkin CF, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters - a randomized prospective trial. Ann Inter Med 1990;112:423-8.
8. Levine M, Hirsh J, Gent M, Arnold A, Warr D, Falanga A et al. Double-blind randomized trial of very-low-dose warfarin for prevention of thromboembolism in stage-IV breast-cancer. Lancet 1994;343:886-9.
9. Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices - prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996; 75:251-3.
10. Heaton DC, Han DY, Inder A. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J 2002;32:84-8.
11. Verso M, Agnelli G, Bertoglio S, Di Somma FC, Paoletti F, Ageno W, et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: A double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 2005;23:4057-62.
12. Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 2005; 23:4063-9.
13. Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B, et al. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb Res 2003;109:101-8.
14. Nowak-Gottl U, Kosch A, Schlegel N. Thromboembolism in newborns, infants and children. Thromb Haemost 2001;86: 464-74.
15. Ruud E, Holmstrom H, Natvig S, Wesenberg F. Prevalence of thrombophilia and central venous catheter-associated neck vein thrombosis in 41 children with cancer - a prospective study. Med Pediatr Oncol 2002;38:405-10.
16. Wittkowsky AK, Devine EB. Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin. Pharmacotherapy 2004;24:1311-6.
17. Veeger NJGM, Piersma-Wichers M, Tijssen JGP, Hillege HL, Meer J. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism. Brit J Haematol 2005;128:513-9.
18. Newall F, Barnes C, Savoia H, Campbell J, Monagle P. Warfarin therapy in children who require long-term total parenteral nutrition. Pediatrics 2003;112:E386-8.
19. Masci G, Magagnoli M, Zucali PA, Castagna L, Carnaghi C, Sarina B, et al. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy? J Clin Oncol 2003;21:736-9.
20. Lee AYY. Anti-thrombotic therapy in cancer patients. Expert Opin Pharmacother 2003;4:2213-20.
21. Chan AK, Deveber G, Monagle P, Brooker LA, Massicotte PM. Venous thrombosis in children. J Thromb Haemost 2003; 1:1443-55.
22. Lordick F, Hentrich M, Decker T, Hennig M, Pohlmann H, Hartenstein R, et al. Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter-related infections in patients with haemato-oncological diseases: a prospective observational study. Brit J Haematol 2003;120:1073-8.
23. Male C, Chait P, Ginsberg JS, Hanna K, Andrew M, Halton J, et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children - results of the PARKAA study. Thromb Haemost 2002;87:593-8.
24. Chait P, Dinyari M, Massicotte MP. The sensitivity and specificity of lineograms and ultrasound compared to venography for the diagnosis of central venous line related thrombosis in symptomatic children: the LUV study. Thromb Haemost 2001;Suppl:697.
25. Xiang DZ, Verbeken EK, Van Lommel ATL, Stas M, De Wever L. Sleeve-related thrombosis - a new form of catheter-related thrombosis. Thromb Res 2001;104:7-14.
26. Nowak-Gottl U, Wermes C, Junker R, Koch HG, Schobess R, Fleischhack G, et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 1999; 93:1595-9.
27. Knofler R, Siegert E, Lauterbach I, Taut-Sack H, Siegert G, Gehrisch S, et al. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy - impact of central venous lines. Eur J Pediatr 1999;158:S147-50.
28. Ehrenforth S, Junker R, Koch HG, Kreuz W, Munchow N, Scharrer I, et al. Multicentre evaluation of combined prothrombotic: defects associated with thrombophilia in childhood. Eur J Pediatr 1999;158:S97-104.